Toshiki Okazaki

Sendai, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Successful treatment of multiple phototherapy-induced cutaneous squamous cell carcinomas with nivolumab monotherapy.

Successful treatment of multiple phototherapy-induced cutaneous squamous cell carcinomas with nivolumab monotherapy.

Journal: European journal of dermatology : EJD
Published: August 28, 2026

Association between Psoriasis Area and Severity Index Score and atherosclerotic risk in psoriasis patients using the Hisayama Score: a single-center retrospective study.

Association between Psoriasis Area and Severity Index Score and atherosclerotic risk in psoriasis patients using the Hisayama Score: a single-center retrospective study.

Journal: Immunological medicine
Published: March 17, 2026

Ritlecitinib in Alopecia Areata: A 24-Week Real-World Experience Contrasting JAK Inhibitor-Naïve and JAK Inhibitor-Experienced Patients.

Ritlecitinib in Alopecia Areata: A 24-Week Real-World Experience Contrasting JAK Inhibitor-Naïve and JAK Inhibitor-Experienced Patients.

Journal: The Journal of dermatology
Published: October 05, 2025

Coronary Artery Disease Assessment in Psoriasis Patients Well-Controlled Under Systemic Anti-Inflammatory Treatments-A Real-World Observational Study From a Single Center.

Coronary Artery Disease Assessment in Psoriasis Patients Well-Controlled Under Systemic Anti-Inflammatory Treatments-A Real-World Observational Study From a Single Center.

Journal: The Journal of dermatology
Published: September 19, 2025

A case of plexiform schwannoma arising in a patient with neurofibromatosis type 2.

A case of plexiform schwannoma arising in a patient with neurofibromatosis type 2.

Journal: European journal of dermatology : EJD
Published: September 18, 2025

A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib.

A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib.

Journal: JAAD case reports
Published: August 11, 2025

Disseminated maculopapular drug eruption caused by ritlecitinib in a patient with alopecia areata.

Disseminated maculopapular drug eruption caused by ritlecitinib in a patient with alopecia areata.

Journal: European journal of dermatology : EJD
Published: July 31, 2025

Long-Term Real-World Outcomes of Baricitinib in Severe Alopecia Areata: A 104-Week Retrospective Analysis From a Single Institute.

Long-Term Real-World Outcomes of Baricitinib in Severe Alopecia Areata: A 104-Week Retrospective Analysis From a Single Institute.

Journal: The Journal of dermatology
Published: March 30, 2025

Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center.

Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center.

Journal: The Journal of dermatology
Published: October 12, 2024

Multiple squamous cell carcinomas in situ in a patient with lung cancer treated with tepotinib.

Multiple squamous cell carcinomas in situ in a patient with lung cancer treated with tepotinib.

Journal: European journal of dermatology : EJD
Published: July 17, 2024

Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome associated with acute-on-chronic pancreatitis: A case report.

Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome associated with acute-on-chronic pancreatitis: A case report.

Journal: The Journal of dermatology
Published: April 07, 2024

Eosinophilic annular erythema successfully treated with dupilumab: A case report.

Eosinophilic annular erythema successfully treated with dupilumab: A case report.

Journal: The Journal of dermatology
Published: December 26, 2023
Showing 1-12 of 12

Last Updated: 09/26/2026